Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 165
Filter
Add more filters

Publication year range
1.
AIDS Care ; 32(4): 411-419, 2020 04.
Article in English | MEDLINE | ID: mdl-31280587

ABSTRACT

Successful vertical HIV transmission prevention programmes (VTP) have resulted in an expanding population of HIV-exposed uninfected (HEU) infants whose growth, health and neurodevelopmental outcomes could have consequences for future resource allocation. We compared neurodevelopmental and behavioural outcomes in a prospective cohort of 2-3 year old HEU and HIV-unexposed uninfected (HU) children.Women living with and without HIV and their infants were enrolled within three days of birth from a low-risk midwife obstetric unit in Cape Town, South Africa during 2012 and 2013, under WHO Option A VTP guidelines. HIV-uninfected children aged 30-42 months were assessed using the Bayley scales of Infant Development-Third edition (BSID) and Strengths and Difficulties questionnaire (SDQ).Thirty-two HEU and 27 HU children (mean birth weight 3048g vs 3096g) were assessed. HEU children performed as well as HU children on BSID cognitive, language and motor domains. Mean scores fell within the low average range. Mothers of HEU children reported fewer conduct problems but stunting was associated with increased total difficulties on the SDQ.HEU and HU children's performance on the BSID was similar. In this low-risk cohort, HIV exposure did not confer additional risk. Stunting was associated with increased behavioural problems irrespective of HIV exposure.


Subject(s)
Child Behavior Disorders/etiology , Child Development/physiology , HIV Infections/complications , Infant Health/statistics & numerical data , Neurodevelopmental Disorders/epidemiology , Pregnancy Complications, Infectious/drug therapy , Prenatal Exposure Delayed Effects/epidemiology , Anti-HIV Agents/therapeutic use , Breast Feeding , Child Behavior Disorders/psychology , Child Development/drug effects , Child, Preschool , Female , HIV Infections/drug therapy , HIV Infections/epidemiology , Humans , Infant , Infectious Disease Transmission, Vertical , Male , Mothers , Neurodevelopmental Disorders/etiology , Neuropsychological Tests , Pregnancy , Pregnancy Complications, Infectious/virology , Prenatal Exposure Delayed Effects/virology , Prospective Studies , South Africa/epidemiology , Treatment Outcome
2.
Antimicrob Agents Chemother ; 58(4): 2229-34, 2014.
Article in English | MEDLINE | ID: mdl-24492365

ABSTRACT

Isoniazid (INH) is recommended for use as posttuberculosis exposure preventive therapy in children. However, no pharmacokinetic data are available for INH treatment in low-birth-weight (LBW) infants, who undergo substantial developmental and physiological changes. Our objectives in this study were to determine the pharmacokinetic parameters of INH at a dose of 10 mg/kg of body weight/day and to define its pharmacokinetics relative to the arylamine N-acetyltransferase-2 (NAT2) genotype. An intensive prospective pharmacokinetic sampling study was conducted at Tygerberg Children's Hospital, South Africa, in which we measured INH blood plasma concentrations at 2, 3, 4 and 5 h postdose. Twenty LBW infants (14 male, 16 exposed to HIV) were studied. The median birth weight was 1,575 g (interquartile range, 1,190 to 2,035 g) and the median gestational age was 35 weeks (interquartile range, 34 to 38 weeks). The NAT2 acetylation statuses of the infants were homozygous slow (SS) (5 infants), heterozygous intermediate (FS) (11 infants), and homozygous fast (FF) (4 infants). Using a noncompartmental analysis approach, the median maximum drug concentration in blood serum (Cmax) was 5.63 µg/ml, the time after drug administration to reach CmaxTmax) was 2 h, the area under the concentration-time curve from 2 to 5 h (AUC2-5) was 13.56 µg · h/ml, the half-life (t1/2) was 4.69 h, and the elimination constant rate (kel) was 0.15 h(-1). The alanine aminotransferase levels were normal, apart from 2 isolated values at two and three times above the normal levels. Only the three-times-elevated value was repeated at 6 months and normalized. All LBW infants achieved target INH blood plasma concentrations comparable to the adult values. Reduced elimination was observed in smaller and younger infants and in slow acetylators, cautioning against higher doses. The safety data, although limited, were reassuring. More data, however, are required for newborn infants.


Subject(s)
Antitubercular Agents/pharmacokinetics , Isoniazid/pharmacokinetics , Antitubercular Agents/therapeutic use , Arylamine N-Acetyltransferase/metabolism , Female , Genotype , Humans , Infant, Low Birth Weight , Infant, Newborn , Isoniazid/therapeutic use , Male , Prospective Studies , Tuberculosis/drug therapy
3.
Int J Tuberc Lung Dis ; 27(8): 619-625, 2023 08 01.
Article in English | MEDLINE | ID: mdl-37491747

ABSTRACT

BACKGROUND: P1041 was a randomised, placebo-controlled isoniazid prophylaxis trial in South Africa. We studied predictors for TB in HIV-exposed children participating in the P1041 trial.METHODS: We included data from entry until Week 108. Predictors considered were type of housing, overcrowding, age, sex, ethnicity, tobacco exposure, weight-for-age percentile Z-score (WAZ), CD4%, viral load (VL), antiretroviral therapy (ART) and number of household smokers.RESULTS: Of 543 HIV-positive (HIV+) and 808 HIV-exposed uninfected (HEU) infants at entry, median age was 96 days (interquartile range: 92-105). Of 1,351 caregivers, 125 (9%) had a smoking history, and 62/1,351 reported current smoking. In 594/1,351 (44%) households, there was at least one smoker. Smoking caregivers consumed 1-5 cigarettes daily. In the HIV+ cohort, significant baseline TB predictors after adjusting covariates were as follows: WAZ (adjusted hazard ratio [aHR] 0.76, P = 0.002) and log10 HIV RNA copies/ml (aHR 1.50, P = 0.009). Higher CD4% (aHR 0.88, P = 0.002) and ART (aHR 0.50, P = 0.006) were protective. In the HEU cohort, smoking exposure was associated with reduced TB-free survival on univariate analysis, but not after adjustment in the multivariate model.CONCLUSION: Low WAZ and high VL were strong predictors of TB disease or death. Rising CD4 percentage and being on ART were protective in the HIV+ cohort.


Subject(s)
HIV Infections , Tuberculosis , Infant , Humans , Child , Tuberculosis/epidemiology , HIV Infections/drug therapy , HIV Infections/epidemiology , Africa, Southern , South Africa/epidemiology , Isoniazid/therapeutic use
4.
Thorax ; 66(6): 496-501, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21460373

ABSTRACT

BACKGROUND: Tuberculosis (TB) is a major cause of morbidity and mortality among children infected with HIV. Strategies to prevent TB in children include isoniazid preventive therapy (IPT) and antiretroviral therapy (ART). IPT and ART have been reported to reduce TB incidence in adults but there are few studies in children. OBJECTIVE: To investigate the combined effect of IPT and ART on TB risk in children infected with HIV. METHODS: A cohort analysis was done within a prospective, double-blinded, placebo-controlled trial of isoniazid (INH) compared with placebo in children infected with HIV in Cape Town, South Africa, a high TB incidence setting. In May 2004 the placebo arm was terminated and all children were switched to INH. ART was not widely available at the start of the study, but children were started on ART following the establishment of the national ART program in 2004. Data were analysed using Cox proportional hazard regression. RESULTS: After adjusting for age, nutritional status and immunodeficiency at enrolment, INH alone, ART alone and INH combined with ART reduced the risk of TB disease by 0.22 (95% CI 0.09 to 0.53), 0.32 (95% CI 0.07 to 1.55) and 0.11 (95% CI 0.04 to 0.32) respectively. INH reduced the risk of TB disease in children on ART by 0.23 (95% CI 0.05 to 1.00). CONCLUSIONS: The finding that IPT may offer additional protection in children on ART has significant public health implications because this offers a possible strategy for reducing TB in children infected with HIV. Widespread use of this strategy will however require screening of children for active TB disease. Trial registration Trial registration-Clinical Trials NCT00330304.


Subject(s)
AIDS-Related Opportunistic Infections/prevention & control , Anti-HIV Agents/therapeutic use , Antitubercular Agents/therapeutic use , Isoniazid/therapeutic use , Tuberculosis/prevention & control , AIDS-Related Opportunistic Infections/epidemiology , Child , Child, Preschool , Drug Therapy, Combination , Epidemiologic Methods , Female , HIV Infections/drug therapy , Humans , Incidence , Infant , Male , South Africa/epidemiology , Treatment Outcome , Tuberculosis/epidemiology
5.
Nat Med ; 1(2): 129-34, 1995 Feb.
Article in English | MEDLINE | ID: mdl-7585008

ABSTRACT

Although 13 years have passed since identification of human immunodeficiency virus-1 (HIV-1) as the cause of AIDS, we do not yet know how HIV kills its primary target, the T cell that carries the CD4 antigen. We and others have shown an increase in the percentage of apoptotic cells among circulating CD4+ (and CD8+) T cells of HIV-seropositive individuals and an increase in frequency of apoptosis with disease progression. However, it is not known if this apoptosis occurs in infected or uninfected T cells. We show here, using in situ labelling of lymph nodes from HIV-infected children and SIV-infected macaques, that apoptosis occurs predominantly in bystander cells and not in the productively infected cells themselves. These data have implications for pathogenesis and therapy, namely, arguing that rational drug therapy may involve combination agents targeting viral replication in infected cells and apoptosis of uninfected cells.


Subject(s)
Apoptosis , HIV Infections/virology , Lymph Nodes/pathology , Simian Acquired Immunodeficiency Syndrome/virology , Animals , Child , Child, Preschool , Female , HIV Infections/pathology , HIV-1/pathogenicity , Humans , Lymph Nodes/virology , Macaca , Male , RNA, Messenger/analysis , RNA, Viral/analysis , Simian Acquired Immunodeficiency Syndrome/pathology , Simian Immunodeficiency Virus/pathogenicity , T-Lymphocytes/virology
6.
Paediatr Respir Rev ; 12(1): 39-45, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21172674

ABSTRACT

The human immunodeficiency virus (HIV) epidemic has had a major impact on the age and gender profile of adult tuberculosis (TB) patients, resulting in increased exposure of HIV-infected and uninfected children at a very young age. Young and/or HIV-infected children are extremely vulnerable to develop severe forms of TB following recent exposure and infection. There is an urgent need to implement safe and pragmatic strategies to prevent TB in children, especially in TB endemic areas where they suffer the greatest burden of disease. The management of TB in HIV-infected children poses multiple challenges, but recent advances in the implementation of prevention of mother to child transmission (PMTCT) strategies and HIV care of infants offer hope. These include HIV testing and access to PMTCT for all pregnant women, routine testing of all HIV exposed infants and rapid initiation of antiretroviral treatment irrespective of clinical or immunological disease staging. In addition, careful scrutiny for TB exposure should occur at every health care visit, with provision of isoniazid preventive therapy (IPT) following each documented exposure event. Knowing the HIV infection status of child TB suspects is essential to optimize case management. Although multiple difficulties remain, recent advances demonstrate that the management of children with TB and/or HIV can be vastly improved by well focused interventions using readily available resources.


Subject(s)
HIV Infections/prevention & control , Pregnancy Complications, Infectious/prevention & control , Tuberculosis/prevention & control , Adult , Anti-Retroviral Agents/therapeutic use , Child , Child, Preschool , Female , HIV Infections/complications , HIV Infections/diagnosis , Humans , Infant , Male , Pregnancy , Pregnancy Complications, Infectious/diagnosis , Pregnancy Complications, Infectious/etiology , Tuberculosis/complications , Tuberculosis/diagnosis
7.
Ann Trop Paediatr ; 31(2): 185-8, 2011.
Article in English | MEDLINE | ID: mdl-21575327

ABSTRACT

Congenital measles is a well recognised but uncommon transplacental infection in the post-vaccine era. A 4-day-old infant is described who presented with uncomplicated congenital measles during the 2010 South African measles outbreak. Clinicians working in regions affected by measles outbreaks should be mindful of waning vaccine-induced measles immunity where infections among pregnant women may result in a resurgence of congenital measles.


Subject(s)
Measles/congenital , Measles/diagnosis , Adult , Disease Outbreaks , Female , Humans , Infant, Newborn , Male , Measles/epidemiology , South Africa/epidemiology
8.
Antimicrob Resist Infect Control ; 10(1): 35, 2021 02 12.
Article in English | MEDLINE | ID: mdl-33579364

ABSTRACT

BACKGROUND: Contamination of the hospital environment contributes to neonatal bacterial colonization and infection. Cleaning of hospital surfaces and equipment is seldom audited in resource-limited settings. METHODS: A quasi-experimental study was conducted to assess the impact of a multimodal cleaning intervention for surfaces and equipment in a 30-bed neonatal ward. The intervention included cleaning audits with feedback, cleaning checklists, in-room cleaning wipes and training of staff and mothers in cleaning methods. Cleaning adequacy was evaluated for 100 items (58 surfaces, 42 equipment) using quantitative bacterial surface cultures, adenosine triphosphate bioluminescence assays and fluorescent ultraviolet markers, performed at baseline (P1, October 2019), early intervention (P2, November 2019) and late intervention (P3, February 2020). RESULTS: Environmental swabs (55/300; 18.3%) yielded growth of 78 potential neonatal pathogens with Enterococci, S. marcescens, K. pneumoniae, S. aureus and A. baumannii predominating. Highest aerobic colony counts were noted from moist surfaces such as sinks, milk kitchen surfaces, humidifiers and suction tubing. The proportion of surfaces and equipment exhibiting no bacterial growth increased between phases (P1 = 49%, P2 = 66%, P3 = 69%; p = 0.007). The proportion of surfaces and equipment meeting the ATP "cleanliness" threshold (< 200 relative light units) increased over time (P1 = 40%, P2 = 54%, P3 = 65%; p = 0.002), as did the UV marker removal rate (P1 = 23%, P2 = 71%, P3 = 74%; p < 0.001). CONCLUSION: Routine environmental cleaning of this neonatal ward was sub-optimal at baseline but improved significantly following a multimodal cleaning intervention. Involving mothers and nursing staff was key to achieving improved environmental and equipment cleaning in this resource-limited neonatal unit.


Subject(s)
Cross Infection/prevention & control , Disinfection/methods , Infection Control/methods , Bacteria/isolation & purification , Checklist , Clinical Audit , Equipment Contamination/prevention & control , Hospitals, Public , Hospitals, Teaching , Humans , Infant, Newborn , Mothers , Personnel, Hospital , South Africa
9.
AIDS Care ; 22(6): 751-8, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20467942

ABSTRACT

With the increasing availability of highly active antiretroviral therapy, vertically infected children have a better chance of surviving into adolescence and adulthood. Additionally, sexual transmission of human immunodeficiency virus (HIV) remains a problem, and incidence and prevalence among youth remain high. Therefore, HIV-infected adolescents are becoming a more prominent sub-group in the HIV/AIDS epidemic. Experience from the developed world indicates that providing effective care and treatment for adolescents poses unique challenges. This study aimed to identify the experiences and needs of adolescents growing up in care or on treatment for HIV in Cape Town, South Africa. Four focus groups interviews were conducted with a total of 26 young people attending an adolescent infectious diseases clinic at a tertiary hospital. Questions explored participant's perceptions on their present and future lives, and their self-identified needs. Focus groups revealed that adolescents viewed their illness negatively, but that social issues such as violence and poverty were also concerns. Despite these stressors, most respondents remained positive about the present and future, and wanted support for achieving their goals. As increasing numbers of HIV-infected children enter adolescence, healthcare providers and communities must find ways to support these young people to transition into adulthood.


Subject(s)
Antiretroviral Therapy, Highly Active , HIV Infections/psychology , Social Problems , Adolescent , Adolescent Health Services , Attitude to Health , Child , Female , Focus Groups , HIV Infections/drug therapy , Humans , Male , Needs Assessment , Qualitative Research , South Africa , Violence
10.
J Trop Pediatr ; 56(2): 75-81, 2010 Apr.
Article in English | MEDLINE | ID: mdl-19602487

ABSTRACT

We describe the clinical and basic immunological findings of eight HIV-exposed uninfected infants hospitalized with serious infectious morbidity and referred for immunological evaluation. The median age at presentation was 5.5 (1.5-15) months. Infections included Pneumocystis jiroveci pneumonia (three), cytomegalovirus colitis with perforation (one), Pseudomonas sepsis (two), hemorrhagic varicella (one) and Group A streptococcal meningitis and endocarditis (one). Five required intensive care, four for assisted ventilation and one for post-surgical care. Follow-up to 36 months suggested resolution of a transient immunodeficiency in two infants, one of whom had CD4 and the other B-cell depletion. Further studies are indicated in HIV-exposed uninfected infants.


Subject(s)
HIV Infections , HIV-1 , Immunocompromised Host , Infections/immunology , Female , Follow-Up Studies , HIV Infections/transmission , Humans , Infant , Length of Stay , Morbidity , Pneumocystis carinii/isolation & purification , Pneumonia, Pneumocystis/diagnosis , Pregnancy , Retrospective Studies , Risk Factors
11.
J Trop Pediatr ; 56(2): 97-102, 2010 Apr.
Article in English | MEDLINE | ID: mdl-19656842

ABSTRACT

OBJECTIVE: To determine the prevalence of attention deficit-hyperactivity disorder (ADHD) and oppositional defiance disorder (ODD) in HIV-infected South African children. METHODS: Swanson, Nolan and Pelham (SNAP-IV) questionnaires were used to determine ADHD and ODD severity and a draw-a-person (DAP) test was used to screen for developmental disorders. Associations between behavioural subtypes, psychological functioning, demographic and health variables were investigated. RESULTS: The SNAP-IV caregiver questionnaires showed a 26% prevalence of ADHD inattentive type; 38% hyperactive type and 24% combined type. The prevalence of ODD was 12% on parent questionnaires and 9.5% on teacher's questionnaires. CONCLUSIONS: Parents/caregiver-only SNAP-IV questionnaires indicate a high prevalence of significant ADHD (all subtypes) and ODD in HIV-infected children. No significant differences were found between the severity of HIV disease and the presence of a behavioural disorder. The SNAP IV questionnaires and DAP test may prove valuable screening tools in HIV children with behavioural problems.


Subject(s)
Attention Deficit Disorder with Hyperactivity/epidemiology , Attention Deficit and Disruptive Behavior Disorders/epidemiology , HIV Infections/epidemiology , HIV-1 , Parents/psychology , Attention Deficit Disorder with Hyperactivity/complications , Attention Deficit Disorder with Hyperactivity/diagnosis , Attention Deficit Disorder with Hyperactivity/psychology , Attention Deficit and Disruptive Behavior Disorders/complications , Attention Deficit and Disruptive Behavior Disorders/diagnosis , Attention Deficit and Disruptive Behavior Disorders/psychology , Black People , Caregivers , Child , Child, Preschool , Female , HIV Infections/complications , Humans , Male , Mental Disorders/diagnosis , Prevalence , Psychometrics , Severity of Illness Index , Socioeconomic Factors , South Africa , Teaching
12.
Psychol Health Med ; 15(3): 278-87, 2010 May.
Article in English | MEDLINE | ID: mdl-20480433

ABSTRACT

Maternal postpartum depression poses significant risks for mother-child interaction and long-term infant outcomes. Human immunodeficiency virus (HIV) status has also been implicated in the development of postpartum depression, but the association between maternal depression and infant social behavior in the context of HIV infection has not been fully investigated. First, we examined the relationship between maternal postpartum depression and infant social withdrawal at 10-12 months of age in HIV-infected mothers and infants. Second, we ascertained whether infant social withdrawal could be significantly predicted by maternal postpartum depression. The sample consisted of 83 HIV-infected mother-infant dyads. Mothers were assessed for postpartum depression with the Edinburgh Postnatal Depression Scale (EPDS), and infant social withdrawal behavior was rated using the Modified Alarm Distress Baby Scale (m-ADBB). 42.2% of the mothers scored above the cut-off point for depression on the EPDS, and a third of infants (31%) were socially withdrawn. Notably, maternal depression did not predict infant social withdrawal as measured by the m-ADBB. Infant social withdrawal was also not significantly associated with failure to thrive or gender. These preliminary findings need further investigation with respect to the impact on long-term neurodevelopmental and behavioral outcomes.


Subject(s)
Depression, Postpartum , HIV Infections/psychology , Mother-Child Relations , Adolescent , Adult , Cross-Sectional Studies , Female , HIV Infections/drug therapy , Humans , Infant , Infant Behavior , Middle Aged , Social Isolation/psychology , Young Adult
13.
Int J Infect Dis ; 98: 315-320, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32615324

ABSTRACT

BACKGROUND: Vertical transmission is the predominant route for acquisition of HIV infection in children, either in utero, intrapartum or postnatally through breast feeding. Less frequently, children may acquire HIV by horizontal transmission. Horizontal transmission may be healthcare-associated (infusion of HIV-contaminated blood products, use of contaminated needles, syringes and medical equipment, or through ingestion of HIV in expressed breastmilk). Community-acquired HIV transmission to children may occur following surrogate breastfeeding, pre-mastication of food, and sexual abuse. METHODS: Children with suspected horizontally acquired HIV infection were identified by retrospective folder review of existing patients (2004-2014) and by prospective interview and examination of new patients (from 2009 onwards), at a hospital-based paediatric antiretroviral clinic in Cape Town, South Africa. The global literature on horizontal HIV transmission to children (1 January 1986-1 November 2019) was reviewed, to contextualize the local findings. RESULTS: Among the 32 children with horizontal HIV transmission (15 identified retrospectively and 17 prospectively), the median age at first diagnosis was 79 months (interquartile range 28.5-91.5); most children (90.6%) had advanced HIV disease at presentation. HIV transmission was considered healthcare-associated in 15 (46.9%), community-associated in ten (31.3%), possibly healthcare or community-associated in five (15.6 %); and unknown in two children (6.3%). CONCLUSION: Horizontal HIV transmission to children is an important public health issue, with prevention efforts requiring intervention at healthcare facility- and community-level. Greater effort should be made to promptly identify and comprehensively investigate each horizontally HIV-infected child to establish possible routes of transmission and inform future prevention strategies.


Subject(s)
HIV Infections/transmission , Infectious Disease Transmission, Vertical/statistics & numerical data , Adult , Anti-HIV Agents/therapeutic use , Child , Child, Preschool , Female , HIV Infections/drug therapy , HIV Infections/epidemiology , HIV Infections/virology , HIV-1/genetics , HIV-1/physiology , Humans , Infant , Male , Prospective Studies , Retrospective Studies , South Africa/epidemiology , Young Adult
14.
Int J Infect Dis ; 99: 334-337, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32763447

ABSTRACT

Estimates of health capacities in the context of the coronavirus disease 2019 (COVID-19) pandemic indicate that most low- and middle-income countries (LMICs) are not operationally ready to manage this health emergency. Motivated by worldwide successes in other infectious disease epidemics and our experience in Sub-Saharan Africa, we support mobile phone communication to improve data collection and reporting, communication between healthcare workers, public health institutions, and patients, and the implementation of disease tracking and subsequent risk-stratified isolation measures. Programmatic action is needed for centrally coordinated reporting and communication systems facilitating mobile phones in crisis management plans for addressing the COVID-19 pandemic in LMICs. We summarize examples of worldwide mobile phone technology initiatives that have enhanced patient care and public health outcomes in previous epidemics and the current COVID-19 pandemic. In addition, we provide an overview of baseline conditions, including transparency about privacy guarantees, necessary for the successful use of mobile phones in assisting in the fight against COVID-19 spread.


Subject(s)
Betacoronavirus/physiology , Cell Phone , Coronavirus Infections/epidemiology , Pandemics , Pneumonia, Viral/epidemiology , COVID-19 , Coronavirus Infections/virology , Developing Countries , Health Information Systems , Health Personnel , Humans , Pneumonia, Viral/virology , Poverty , SARS-CoV-2 , Telemedicine
15.
S Afr Med J ; 110(6): 463-465, 2020 04 23.
Article in English | MEDLINE | ID: mdl-32880553

ABSTRACT

While many countries are preparing to face the COVID-19 pandemic, the reported cases in Africa remain low. With a high burden of both communicable and non-communicable disease and a resource-constrained public healthcare system, sub-Saharan Africa is preparing for the coming crisis as best it can. We describe our early response as a designated COVID-19 provincial hospital in Cape Town, South Africa (SA).While the first cases reported were related to international travel, at the time of writing there was evidence of early community spread. The SAgovernment announced a countrywide lockdown from midnight 26 March 2020 to midnight 30 April 2020 to stem the pandemic and save lives. However, many questions remain on how the COVID-19 threat will unfold in SA, given the significant informal sector overcrowding and poverty in our communities. There is no doubt that leadership and teamwork at all levels is critical in influencing outcomes.


Subject(s)
Coronavirus Infections/epidemiology , Hospitals , Leadership , Pneumonia, Viral/epidemiology , COVID-19 , Coronavirus Infections/therapy , Humans , Pandemics , Pneumonia, Viral/therapy , Poverty , South Africa/epidemiology
16.
Clin Infect Dis ; 48(1): 108-14, 2009 Jan 01.
Article in English | MEDLINE | ID: mdl-19049436

ABSTRACT

BACKGROUND: There are limited population-based estimates of tuberculosis incidence among human immunodeficiency virus (HIV)-infected and HIV-uninfected infants aged < or =12 months. We aimed to estimate the population-based incidence of culture-confirmed tuberculosis among HIV-infected and HIV-uninfected infants in the Western Cape Province, South Africa. METHODS: The incidences of pulmonary, extrapulmonary, and disseminated tuberculosis were estimated over a 3-year period (2004-2006) with use of prospective representative hospital surveillance data of the annual number of culture-confirmed tuberculosis cases among infants. The total number of HIV-infected and HIV-uninfected infants was calculated using population-based estimates of the total number of live infants and the annual maternal HIV prevalence and vertical HIV transmission rates. RESULTS: There were 245 infants with culture-confirmed tuberculosis. The overall incidences of tuberculosis were 1596 cases per 100,000 population among HIV-infected infants (95% confidence interval [CI], 1151-2132 cases per 100,000 population) and 65.9 cases per 100,000 population among HIV-uninfected infants (95% CI, 56-75 cases per 100,000 population). The relative risk of culture-confirmed tuberculosis among HIV-infected infants was 24.2 (95% CI, 17-34). The incidences of disseminated tuberculosis were 240.9 cases per 100,000 population (95% CI, 89-433 cases per 100,000 population) among HIV-infected infants and 14.1 cases per 100,000 population (95% CI, 10-18 cases per 100,000 population) among HIV-uninfected infants (relative risk, 17.1; 95% CI, 6-34). CONCLUSIONS: This study indicates the magnitude of the tuberculosis disease burden among HIV-infected infants and provides population-based comparative incidence rates of tuberculosis among HIV-infected infants. This high risk of tuberculosis among HIV-infected infants is of great concern and may be attributable to an increased risk of tuberculosis exposure, increased immune-mediated tuberculosis susceptibility, and/or possible limited protective effect of bacille Calmette-Guérin vaccination. Improved tuberculosis control strategies, including maternal tuberculosis screening, contact tracing of tuberculosis-exposed infants coupled with preventive chemotherapy, and effective vaccine strategies, are needed for infants in settings where HIV infection and tuberculosis are highly endemic.


Subject(s)
HIV Infections/complications , Tuberculosis/epidemiology , Humans , Incidence , Infant , Infant, Newborn , Mycobacterium tuberculosis/isolation & purification , South Africa/epidemiology
18.
Science ; 281(5375): 375-88, 1998 Jul 17.
Article in English | MEDLINE | ID: mdl-9665876

ABSTRACT

The complete genome sequence of Treponema pallidum was determined and shown to be 1,138,006 base pairs containing 1041 predicted coding sequences (open reading frames). Systems for DNA replication, transcription, translation, and repair are intact, but catabolic and biosynthetic activities are minimized. The number of identifiable transporters is small, and no phosphoenolpyruvate:phosphotransferase carbohydrate transporters were found. Potential virulence factors include a family of 12 potential membrane proteins and several putative hemolysins. Comparison of the T. pallidum genome sequence with that of another pathogenic spirochete, Borrelia burgdorferi, the agent of Lyme disease, identified unique and common genes and substantiates the considerable diversity observed among pathogenic spirochetes.


Subject(s)
Genome, Bacterial , Sequence Analysis, DNA , Treponema pallidum/genetics , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Base Sequence , Borrelia burgdorferi Group/genetics , Carrier Proteins/genetics , Carrier Proteins/metabolism , DNA Repair/genetics , DNA Replication/genetics , DNA Restriction Enzymes/genetics , Energy Metabolism/genetics , Genes, Bacterial , Genes, Regulator , Heat-Shock Response/genetics , Lipoproteins/genetics , Membrane Proteins/genetics , Molecular Sequence Data , Movement , Open Reading Frames , Oxygen Consumption/genetics , Protein Biosynthesis , Recombination, Genetic , Replication Origin , Transcription, Genetic , Treponema pallidum/metabolism , Treponema pallidum/pathogenicity
19.
Science ; 287(5459): 1809-15, 2000 Mar 10.
Article in English | MEDLINE | ID: mdl-10710307

ABSTRACT

The 2,272,351-base pair genome of Neisseria meningitidis strain MC58 (serogroup B), a causative agent of meningitis and septicemia, contains 2158 predicted coding regions, 1158 (53.7%) of which were assigned a biological role. Three major islands of horizontal DNA transfer were identified; two of these contain genes encoding proteins involved in pathogenicity, and the third island contains coding sequences only for hypothetical proteins. Insights into the commensal and virulence behavior of N. meningitidis can be gleaned from the genome, in which sequences for structural proteins of the pilus are clustered and several coding regions unique to serogroup B capsular polysaccharide synthesis can be identified. Finally, N. meningitidis contains more genes that undergo phase variation than any pathogen studied to date, a mechanism that controls their expression and contributes to the evasion of the host immune system.


Subject(s)
Genome, Bacterial , Neisseria meningitidis/genetics , Neisseria meningitidis/pathogenicity , Sequence Analysis, DNA , Antigenic Variation , Antigens, Bacterial/immunology , Bacteremia/microbiology , Bacterial Capsules/genetics , Bacterial Proteins/genetics , Bacterial Proteins/physiology , DNA Transposable Elements , Evolution, Molecular , Fimbriae, Bacterial/genetics , Humans , Meningitis, Meningococcal/microbiology , Meningococcal Infections/microbiology , Molecular Sequence Data , Mutation , Neisseria meningitidis/classification , Neisseria meningitidis/physiology , Open Reading Frames , Operon , Phylogeny , Recombination, Genetic , Serotyping , Transformation, Bacterial , Virulence/genetics
20.
Int J Tuberc Lung Dis ; 13(7): 862-7, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19555536

ABSTRACT

SETTING: Four human immunodeficiency virus (HIV) clinics located at South African tertiary hospitals. OBJECTIVE: To assess the effectiveness of highly active antiretroviral therapy (HAART) in reducing incident tuberculosis (TB) in HIV-infected children. DESIGN: Retrospective cohort. RESULTS: A total of 1132 children's records were included in the study. At entry to the cohort, the median (interquartile range [IQR]) age, CD4%, CD4 count and viral load of all children was respectively 6.3 years (4.1-8.8), 15% (9.0-22.2), 576 cells/mm(3) (287-960) and 160 000 copies/ml (54 941.5-449 683); 75.9% were started on HAART. The male:female ratio was 1:1, and median follow-up time was 1.7 years. In children whose follow-up included both pre-HAART and on-HAART periods, the incidence of clinically diagnosed TB was respectively 21.1 per 100 person-years (py; 95%CI 18.2-24.4) and 6.4/100 py (95%CI 4.8-8.1), and when restricted to confirmed cases, respectively 3.1/100 py (95%CI 2.2-4.2) and 0.8/100 py (95%CI 0.5-1.4). Only 23% of all cases of TB were microbiologically confirmed. Multivariate analyses showed that HAART reduced incident TB by approximately 70%, both for confirmed and all TB cases. CONCLUSIONS: In this high TB burden country, the incidence of diagnosis of TB in HIV-infected children is at least as high as that of adults. HAART reduces incident TB, but further prospective TB preventive and diagnostic studies are urgently needed in children.


Subject(s)
AIDS-Related Opportunistic Infections/epidemiology , AIDS-Related Opportunistic Infections/prevention & control , Antiretroviral Therapy, Highly Active , HIV Infections/drug therapy , Tuberculosis/epidemiology , Tuberculosis/prevention & control , CD4 Lymphocyte Count , Child , Child, Preschool , Female , HIV Infections/epidemiology , Humans , Incidence , Male , Proportional Hazards Models , Retrospective Studies , Risk , South Africa/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL